Top

Archives of Gynecology and Obstetrics

Published in:

01-02-2018 | Review

Reducing the spread of occult uterine sarcoma at the time of minimally invasive gynecologic surgery

Authors: Marron Wong, Rudy Leon De Wilde, Keith Isaacson

Published in: Archives of Gynecology and Obstetrics | Issue 2/2018

Abstract

Purpose

This review covers the most recent evidence to discuss the incidence of occult uterine sarcoma, whether morcellation increases tumor dissemination or mortality, and whether there is a difference between different types of morcellation. We will also discuss techniques to reduce the spread of an undiagnosed uterine sarcoma.

Method

A comprehensive literature search was made in Pubmed, Medline, the Cochrane Library, and Google Scholar for articles related to the incidence of occult uterine sarcoma after morcellation.

Results

Fibroids are benign uterine tumors and are a common indication for gynecologic surgery. Increasingly, gynecologists are approaching these surgeries with minimally invasive techniques. Uterine sarcomas are rare malignant mesenchymal tumors that are difficult to distinguish preoperatively from uterine fibroids.

Conclusion

During a minimally invasive surgery, there is a risk of disseminating an occult sarcoma during tissue extraction. Minimally invasive gynecologists are tasked with balancing taking a minimally invasive approach, which is shown to result in better patient outcomes, with minimizing the risk of spreading an occult sarcoma.

D’Angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116(1):131–139. doi:10.1016/j.ygyno.2009.09.023 CrossRefPubMed

Prat J, Mbatani N (2015) Uterine sarcomas. Int J Gynaecol Obstet. 131(Suppl 2):S105–S110. doi:10.1016/j.ijgo.2015.06.006 CrossRefPubMed

Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS (2008) Endometrial stromal sarcoma: a population-based analysis. Br J Cancer 99(8):1210–1215. doi:10.1038/sj.bjc.6604527 CrossRefPubMedPubMedCentral

Abeler VM, Røyne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB (2009) Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 54(3):355–364. doi:10.1111/j.1365-2559.2009.03231.x CrossRefPubMed

Philip CA, Pautier P, Duffaud F, Ray-Coquard I (2014) High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches. Curr Oncol Rep 16(10):405. doi:10.1007/s11912-014-0405-1 CrossRefPubMed

Tanner EJ, Garg K, Leitao MM, Soslow RA, Hensley ML (2012) High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes. Gynecol Oncol 127(1):27–31. doi:10.1016/j.ygyno.2012.06.030 CrossRefPubMed

Tropé CG, Abeler VM, Kristensen GB (2012) Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol 51(6):694–705. doi:10.3109/0284186X.2012.689111 CrossRefPubMed

Wallach EE, Vlahos NF (2004) Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 104(2):393–406. doi:10.1097/01.AOG.0000136079.62513.39 CrossRefPubMed

Khan AT, Shehmar M, Gupta JK (2014) Uterine fibroids: current perspectives. Int J Womens Health 6:95–114. doi:10.2147/IJWH.S51083 CrossRefPubMedPubMedCentral

10.

Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 8(1):100–107CrossRef

11.

Donnez J, Dolmans MM (2016) Uterine fibroid management: from the present to the future. Hum Reprod Update 22(6):665–686CrossRefPubMed

12.

Vessey MP, Villard-Mackintosh L, McPherson K, Coulter A, Yeates D (1993) The epidemiology of hysterectomy: findings in a large cohort study. Int J Gynecol Obstet 40:184–185. doi:10.1016/0020-7292(93)90413-Q CrossRef

13.

Nieboer TE, Johnson N, Lethaby A, Tavender E, Curr E, Garry R, van Voorst S, Mol BW, Kluivers KB (2009) Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. doi:10.1002/14651858.CD003677 PubMed

14.

Jonsdottir GM, Jorgensen S, Cohen SL, Wright KN, Shah NT, Chavan N, Einarsson JI (2011) Increasing minimally invasive hysterectomy: effect on cost and complications. Obstet Gynecol 117(5):1142–1149. doi:10.1097/AOG.0b013e3182166055 (Erratum in: Obstet Gynecol. 2012;9(1):185. Obstet Gynecol. 2012 Jan; 119(1):186)CrossRefPubMed

15.

ACOG (2009) ACOG Committee Opinion No 444: choosing the route of hysterectomy for benign disease. Obstet Gynecol 114(5):1156–1158. doi:10.1097/AOG.0b013e3181c33c72 CrossRef

16.

AAGL Advancing Minimally Invasive Gynecology Worldwide (2011) AAGL position statement: route of hysterectomy to treat benign uterine disease. J Minim Invasive Gynecol 18(1):1–3. doi:10.1016/j.jmig.2010.10.001 CrossRef

17.

Steiner RA, Wight E, Tadir Y, Haller U (1993) Electrical cutting device for laparoscopic removal of tissue from the abdominal cavity. Obstet Gynecol 81(3):471–474PubMed

18.

Martin L, Shelton J, Goldberg J (2015) The current controversy regarding power morcellation in gynecologic surgery. Womens Health (Lond). 11(6):793–795. doi:10.2217/whe.15.65 CrossRefPubMed

19.

Wright JD (2016) Electric power morcellation in gynecology: the path forward. Obstet Gynecol 127(1):7–9. doi:10.1097/AOG.0000000000001224 CrossRefPubMed

20.

Safety Communications (2014) Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication. Silver Spring, MD: U.S. Food and Drug Administration, April 18, 2014. (Online). http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm393576.htm

21.

Siedhoff MT, Wheeler SB, Rutstein SE, Geller EJ, Doll KM, Wu JM, Clarke-Pearson DL (2015) Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis. Am J Obstet Gynecol. doi:10.1016/j.ajog.2015.03.006 PubMedCentral

22.

Hall T, Lee SI, Boruta DM, Goodman A (2015) Medical device safety and surgical dissemination of unrecognized uterine malignancy: morcellation in minimally invasive gynecologic surgery. Oncologist 20(11):1274–1282. doi:10.1634/theoncologist.2015-0061 CrossRefPubMedPubMedCentral

23.

Ebner F, Friedl TW, Scholz C, Schochter F, Janni W, Vorwerk E, deGregorio N (2015) Is open surgery the solution to avoid morcellation of uterine sarcomas? A systematic literature review on the effect of tumor morcellation and surgical techniques. Arch Gynecol Obstet 292(3):499–506. doi:10.1007/s00404-015-3664-7 CrossRefPubMed

24.

Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I (2009) Clinical management of uterine sarcomas. Lancet Oncol 10(12):1188–1198. doi:10.1016/S1470-2045(09)70226-8 CrossRefPubMed

25.

Parker WH, Fu YS, Berek JS (1994) Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83(3):414–418PubMed

26.

Mahnert N, Morgan D, Campbell D, Johnston C, As-Sanie S (2015) Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications. Obstet Gynecol 125(2):397–405. doi:10.1097/AOG.0000000000000642 CrossRefPubMed

27.

Oduyebo T, Hinchcliff E, Meserve EE, Seidman MA, Quade BJ, Rauh-Hain JA, George S, Nucci MR, del Carmen MG, Muto MG (2016) Risk factors for occult uterine sarcoma among women undergoing minimally invasive gynecologic surgery. J Minim Invasive Gynecol 23(1):34–39. doi:10.1016/j.jmig.2015.07.017 CrossRefPubMed

28.

Bansal N, Herzog TJ, Burke W, Cohen CJ, Wright JD (2008) The utility of preoperative endometrial sampling for the detection of uterine sarcomas. Gynecol Oncol 110(1):43–48. doi:10.1016/j.ygyno.2008.02.026 CrossRefPubMed

29.

Safety Communication (2014) Updated laparoscopic uterine power morcellation in hysterectomy and myomectomy FDA safety communication. Silver Spring, MD: US Food and Drug Administration. November 24, 2014. (Online). http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm424443.htm

30.

Liu FW, Galvan-Turner VB, Pfaendler KS, Longoria TC, Bristow RE (2015) A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature. Am J Obstet Gynecol 212(6):717–724. doi:10.1016/j.ajog.2015.01.012 CrossRefPubMedPubMedCentral

31.

Leibsohn S, d’Ablaing G, Mishell DR Jr, Schlaerth JB (1990) Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 162(4):968–974 (discussion 974–976)CrossRefPubMed

32.

Takamizawa S, Minakami H, Usui R, Noguchi S, Ohwada M, Suzuki M, Sato I (1999) Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas. Gynecol Obstet Invest 48(3):193–196CrossRefPubMed

33.

Seidman MA, Oduyebo T, Muto MG, Crum CP, Nucci MR, Quade BJ (2012) Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms. PLoS ONE 7(11):e50058. doi:10.1371/journal.pone.0050058 CrossRefPubMedPubMedCentral

34.

Rowland M, Lesnock J, Edwards R, Richard S, Zorn K, Sukumvanich P, Krivak T (2012) Occult uterine cancer in patients undergoing laparoscopic hysterectomy with morcellation. Gynecol Oncol 127(1):S29. doi:10.1016/j.ygyno.2012.07.080 CrossRef

35.

Theben JU, Schellong ARM, Altgassen C, Kelling K, Schneider S, Große-Drieling D (2013) Unexpected malignancies after laparoscopic-assisted supracervical hysterectomies (LASH): an analysis of 1,584 LASH cases. Arch Gynecol Obstet 287(3):455–462. doi:10.1007/s00404-012-2559-0 CrossRefPubMed

36.

Tan-Kim J, Hartzell KA, Reinsch CS, O’Day CH, Kennedy JS, Menefee SA, Harrison TA (2015) Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation. Am J Obstet Gynecol. doi:10.1016/j.ajog.2014.12.002 PubMed

37.

Paul PG, Rengaraj V, Das T, Garg R, Thomas M, Khurd AS (2016) Uterine sarcomas in patients undergoing surgery for presumed leiomyomas: 10 years’ experience. J Minim Invasive Gynecol 23(3):384–389. doi:10.1016/j.jmig.2015.11.012 CrossRefPubMed

38.

Picerno TM, Wasson MN, Gonzalez Rios AR, Zuber MJ, Taylor NP, Hoffman MK, Borowsky ME (2016) Int J Gynecol Cancer 26(1):149–155. doi:10.1097/IGC.0000000000000558 CrossRefPubMed

39.

Raine-Bennett T, Tucker LY, Zaritsky E, Littell RD, Palen T, Neugebauer R, Axtell A, Schultze PM, Kronbach DW, Embry-Schubert J, Sundang A, Bischoff K, Compton-Phillips AL, Lentz SE (2016) Occult uterine sarcoma and leiomyosarcoma: incidence of and survival associated with morcellation. Obstet Gynecol 127(1):29–39. doi:10.1097/AOG.0000000000001187 (Erratum in: Obstet Gynecol. 2016 Feb; 127(2):405)CrossRefPubMed

40.

Perkins RB, Handal-Orefice R, Hanchate AD, Lin M, Paasche-Orlow MK (2016) Risk of undetected cancer at the time of laparoscopic supracervical hysterectomy and laparoscopic myomectomy: implications for the use of power morcellation. Womens Health Issues 26:21–26CrossRefPubMed

41.

Pritts EA, Parker WH, Brown J, Olive DL (2015) Outcome of occult uterine leiomyosarcoma after surgery for presumed uterine fibroids: a systematic review. J Minim Invasive Gynecol 22(1):26–33. doi:10.1016/j.jmig.2014.08.781 CrossRefPubMed

42.

Nezhat C, Kho K (2010) Iatrogenic myomas: new class of myomas? J Minim Invasive Gynecol 17(5):544–550. doi:10.1016/j.jmig.2010.04.004 CrossRefPubMed

43.

Thian YL, Tan KH, Kwek JW, Wang J, Chern B, Yam KL (2009) Leiomyomatosis peritonealis disseminata and subcutaneous myoma: a rare complication of laparoscopic myomectomy. Abdom Imaging 34(2):235–238. doi:10.1007/s00261-008-9379-5 CrossRefPubMed

44.

Sizzi O, Rossetti A, Malzoni M, Minelli L, La Grotta F, Soranna L, Panunzi S, Spagnolo R, Imperato F, Landi S, Fiaccamento A, Stola E (2007) Italian multicenter study on complications of laparoscopic myomectomy. J Minim Invasive Gynecol 14(4):453–462. doi:10.1016/j.jmig.2007.01.013 CrossRefPubMed

45.

Paul PG, Koshy AK (2006) Multiple peritoneal parasitic myomas after laparoscopic myomectomy and morcellation. Fertil Steril 85(2):492–493. doi:10.1016/j.fertnstert.2005.10.017 CrossRefPubMed

46.

Ostrzenski A (1997) Uterine leiomyoma particle growing in an abdominal-wall incision after laparoscopic retrieval. Obstet Gynecol 89(5 Pt 2):853–854CrossRefPubMed

47.

Moon HS, Koo JS, Park SH, Park GS, Choi JG, Kim SG (2008) Parasitic leiomyoma in the abdominal wall after laparoscopic myomectomy. Fertil Steril. doi:10.1016/j.fertnstert.2007.08.068

48.

LaCoursiere DY, Kennedy J, Hoffman CP (2005) Retained fragments after total laparoscopic hysterectomy. J Minim Invasive Gynecol 12(1):67–69. doi:10.1016/j.jmig.2004.12.021 CrossRefPubMed

49.

Takeda A, Mori M, Sakai K, Mitsui T, Nakamura H (2007) Parasitic peritoneal leiomyomatosis diagnosed 6 years after laparoscopic myomectomy with electric tissue morcellation: report of a case and review of the literature. J Minim Invasive Gynecol 14(6):770–775. doi:10.1016/j.jmig.2007.07.004 CrossRefPubMed

50.

Ordulu Z, Dal Cin P, Chong WW, Choy KW, Lee C, Muto MG, Quade BJ, Morton CC (2010) Disseminated peritoneal leiomyomatosis after laparoscopic supracervical hysterectomy with characteristic molecular cytogenetic findings of uterine leiomyoma. Genes Chromosom Cancer 49(12):1152–1160. doi:10.1002/gcc.20824 CrossRefPubMedPubMedCentral

51.

Huang PS, Chang WC, Huang SC (2014) Iatrogenic parasitic myoma: a case report and review of the literature. Taiwan J Obstet Gynecol 53(3):392–396. doi:10.1016/j.tjog.2013.11.007 CrossRefPubMed

52.

Kruger PF, Lee P (2014) Disseminated peritoneal leiomyomatosis: a case report and review of current events in the media and the literature: case report. S Afr J Obstet Gynaecol 20(3):91–92. doi:10.7196/SAJOG.874

53.

Della Badia C, Karini H (2010) Endometrial stromal sarcoma diagnosed after uterine morcellation in laparoscopic supracervical hysterectomy. J Minim Invasive Gynecol 17(6):791–793. doi:10.1016/j.jmig.2010.07.001 CrossRefPubMed

54.

Anupama R, Ahmad SZ, Kuriakose S, Vijaykumar DK, Pavithran K, Seethalekshmy NV (2011) Disseminated peritoneal leiomyosarcomas after laparoscopic “myomectomy” and morcellation. J Minim Invasive Gynecol 18(3):386–389. doi:10.1016/j.jmig.2011.01.014 CrossRefPubMed

55.

Oduyebo T, Rauh-Hain AJ, Meserve EE, Seidman MA, Hinchcliff E, George S, Quade B, Nucci MR, Del Carmen MG, Muto MG (2014) The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecol Oncol 132(2):360–365. doi:10.1016/j.ygyno.2013.11.024 CrossRefPubMed

56.

Park JY, Park SK, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH (2011) The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol 122(2):255–259. doi:10.1016/j.ygyno.2011.04.021 CrossRefPubMed

57.

Morice P, Rodriguez A, Rey A, Pautier P, Atallah D, Genestie C, Pomel C, Lhommé C, Haie-Meder C, Duvillard P, Castaigne D (2003) Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients. Eur J Gynaecol Oncol 24(3–4):237–240PubMed

58.

Perri T, Korach J, Sadetzki S, Oberman B, Fridman E, Ben-Baruch G (2009) Uterine leiomyosarcoma: does the primary surgical procedure matter? Int J Gynecol Cancer 19(2):257–260. doi:10.1111/IGC.0b013e31819a1f8f CrossRefPubMed

59.

George S, Barysauskas C, Serrano C, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Demetri GD, Muto MG (2014) Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer 120(20):3154–3158. doi:10.1002/cncr.28844 CrossRefPubMed

60.

Raspagliesi F, Maltese G, Bogani G, Fucà G, Lepori S, De Iaco P, Perrone M, Scambia G, Cormio G, Bogliolo S, Bergamini A, Bifulco G, Casali PG, Lorusso D (2017) Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: a retrospective MITO group study. Gynecol Oncol 144(1):90–95. doi:10.1016/j.ygyno.2016.11.002 CrossRefPubMed

61.

Bogani G, Cliby WA, Aletti GD (2015) Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis. Gynecol Oncol 137(1):167–172. doi:10.1016/j.ygyno.2014.11.011 CrossRefPubMed

62.

Singh SS, Scott S, Bougie O, Leyland N, SOGC Clinical Practice-Gynaecology Committee, Leyland N, Wolfman W, Allaire C, Awadalla A, Bullen A, Burnett M, Goldstein S, Lemyre M, Marcoux V, Potestio F, Rittenberg D, Singh SS, Yeung G, GOC Executive Committee, Hoskins P, Miller D, Gotlieb W, Bernardini M, Hopkins L (2015) Technical update on tissue morcellation during gynaecologic surgery: its uses, complications, and risks of unsuspected malignancy. J Obstet Gynaecol Can 37(1):68–81 (Erratum in: J Obstet Gynaecol Can. 2015;37(2):107. doi:10.1016/S1701-2163(15)30366-2.)CrossRefPubMed

63.

Günthert AR, Christmann C, Kostov P, Mueller MD (2015) Safe vaginal uterine morcellation following total laparoscopic hysterectomy. Am J Obstet Gynecol. doi:10.1016/j.ajog.2014.11.020

64.

Kho KA, Shin JH, Nezhat C (2009) Vaginal extraction of large uteri with the Alexis retractor. J Minim Invasive Gynecol 16(5):616–617. doi:10.1016/j.jmig.2009.06.013 CrossRefPubMed

65.

Wong WS, Lee TC, Lim CE (2010) Novel Vaginal “paper roll” uterine morcellation technique for removal of large (> 500 g) uterus. J Minim Invasive Gynecol 17(3):374–378. doi:10.1016/j.jmig.2010.02.005 CrossRefPubMed

66.

Montella F, Riboni F, Cosma S, Dealberti D, Prigione S, Pisani C, Rovetta E (2014) A safe method of vaginal longitudinal morcellation of bulky uterus with endometrial cancer in a bag at laparoscopy. Surg Endosc 28(6):1949–1953. doi:10.1007/s00464-014-3422-0 CrossRefPubMed

67.

Favero G, Miglino G, Köhler C, Pfiffer T, Silva e Silva A, Ribeiro A, Le X, Anton C, Baracat EC, Carvalho JP (2015) Vaginal morcellation inside protective pouch: a safe strategy for uterine extration in cases of bulky endometrial cancers: operative and oncological safety of the method. J Minim Invasive Gynecol 22(6):938–943. doi:10.1016/j.jmig.2015.04.015 CrossRefPubMed

68.

Solima E, Scagnelli G, Austoni V, Natale A, Bertulessi C, Busacca M, Vignali M (2015) Vaginal uterine morcellation within a specimen containment system: a study of bag integrity. J Minim Invasive Gynecol 22(7):1244–1246. doi:10.1016/j.jmig.2015.07.007 CrossRefPubMed

69.

Serur E, Lakhi N (2011) Laparoscopic hysterectomy with manual morcellation of the uterus: an original technique that permits the safe and quick removal of a large uterus. Am J Obstet Gynecol. doi:10.1016/j.ajog.2011.03.042 PubMed

70.

Hinchcliff EM, Cohen SL (2016) Laparoscopic hysterectomy for uterine fibroids: is it safe? Clin Obstet Gynecol 59(1):66–72. doi:10.1097/GRF.0000000000000165 CrossRefPubMed

71.

Venturella R, Rocca ML, Lico D, La Ferrera N, Cirillo R, Gizzo S, Morelli M, Zupi E, Zullo F (2016) In-bag manual versus uncontained power morcellation for laparoscopic myomectomy: randomized controlled trial. Fertil Steril 105(5):1369–1376. doi:10.1016/j.fertnstert.2015.12.133 CrossRefPubMed

72.

Cohen SL, Einarsson JI, Wang KC, Brown D, Boruta D, Scheib SA, Fader AN, Shibley T (2014) Contained power morcellation within an insufflated isolation bag. Obstet Gynecol 124(3):491–497. doi:10.1097/AOG.0000000000000421 CrossRefPubMed

73.

Kanade TT, McKenna JB, Choi S, Tsai BP, Rosen DM, Cario GM, Chou D (2014) Sydney contained in bag morcellation for laparoscopic myomectomy. J Minim Invasive Gynecol 21(6):981. doi:10.1016/j.jmig.2014.07.005 CrossRefPubMed

74.

Winner B, Porter A, Velloze S, Biest S (2015) Uncontained compared with contained power morcellation in total laparoscopic hysterectomy. Obstet Gynecol 126(4):834–838. doi:10.1097/AOG.0000000000001039 CrossRefPubMed

75.

Cohen SL, Morris SN, Brown DN, Greenberg JA, Walsh BW, Gargiulo AR, Isaacson KB, Wright KN, Srouji SS, Anchan RM, Vogell AB, Einarsson JI (2016) Contained tissue extraction using power morcellation: prospective evaluation of leakage parameters. Am J Obstet Gynecol. doi:10.1016/j.ajog.2015.08.076 PubMedCentral

76.

Food and Drug Administration (2016) FDA allows marketing of first-of-kind tissue containment system for use with certain laparoscopic power morcellators in select patients. Silver Spring, MD: U.S. Food and Drug Administration. Updated April 7, 2016 (Online). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm494650.htm

77.

Isakov A, Murdaugh KM, Burke W, Zimmerman S, Roche E, Holland D, Einarsson JI, Walsh C (2014) A new laparoscopic morcellator using an actuated wire mesh and bag. J Med Devices 8(1):01100917CrossRef

Title: Reducing the spread of occult uterine sarcoma at the time of minimally invasive gynecologic surgery
Authors: Marron Wong
Rudy Leon De Wilde
Keith Isaacson
Publication date: 01-02-2018
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 2/2018
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-017-4575-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Reducing the spread of occult uterine sarcoma at the time of minimally invasive gynecologic surgery

Abstract

Purpose

Method

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2018

Effect of clinical information and previous exam execution on observer agreement and reliability in the analysis of hysteroscopic video-recordings

Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acid

Obstetric care quality indicators and outcomes based on the degree of acculturation of immigrants—results from a cross-sectional study in Berlin

Astragalus polysaccharides increase the sensitivity of SKOV3 cells to cisplatin

Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears

The morbidity of sexual dysfunction of 125 Chinese women following different types of radical hysterectomy for gynaecological malignancies